Drugmakers use real-world patient data to calibrate product development

被引：1
|
作者：
Sheridan, Cormac
机构：
来源：
NATURE BIOTECHNOLOGY | 2011年 / 29卷 / 09期
关键词：
D O I：
10.1038/nbt0911-778b
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：778 / 779
页数：2
相关论文
共 50 条
  • [1] Drugmakers use real-world patient data to calibrate product development
    Cormac Sheridan
    Nature Biotechnology, 2011, 29 : 778 - 779
  • [2] Correction: Corrigendum: Drugmakers use real-world patient data to calibrate product development
    Cormac Sheridan
    Nature Biotechnology, 2012, 30 : 112 - 112
  • [3] Drugmakers use real-world patient data to calibrate product development (vol 29, pg 778, 2011)
    Sheridan, Cormac
    NATURE BIOTECHNOLOGY, 2012, 30 (01) : 112 - 112
  • [4] The use of real-world data in cancer drug development
    Skovlund, E.
    Leufkens, H. G. M.
    Smyth, J. F.
    EUROPEAN JOURNAL OF CANCER, 2018, 101 : 69 - 76
  • [5] The Use of Real-world Data to Generate Real-world Evidence to Accelerate Neonatal Drug Development
    Jackson, Shawn S.
    Cravero, Joseph P.
    Sun, Lena
    Davis, Jonathan M.
    JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 2025, 37 (01) : 110 - 113
  • [6] Understanding Use of Real-World Data and Real-World Evidence to Support Regulatory Decisions on Medical Product Effectiveness
    Mahendraratnam, Nirosha
    Mercon, Kerra
    Gill, Mira
    Benzing, Laura
    McClellan, Mark B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (01) : 150 - 154
  • [7] The use of real-world data to address questions of patient safety
    Yates, Mark
    Bechman, Katie
    Galloway, James
    RHEUMATOLOGY, 2020, 59 (01) : 26 - 30
  • [8] Use of Real-World Data and Real-World Evidence in Rare Disease Drug Development: A Statistical Perspective
    Chen, Jie
    Gruber, Susan
    Lee, Hana
    Chu, Haitao
    Lee, Shiowjen
    Tian, Haijun
    Wang, Yan
    He, Weili
    Jemielita, Thomas
    Song, Yang
    Tamura, Roy
    Tian, Lu
    Zhao, Yihua
    Chen, Yong
    van Der Laan, Mark
    Nie, Lei
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2025, 117 (04) : 946 - 960
  • [9] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
    Richard E. Gliklich
    Michelle B. Leavy
    Therapeutic Innovation & Regulatory Science, 2020, 54 : 303 - 307
  • [10] Assessing Real-World Data Quality: The Application of Patient Registry Quality Criteria to Real-World Data and Real-World Evidence
    Gliklich, Richard E.
    Leavy, Michelle B.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (02) : 303 - 307
12345